Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina S Ilkow

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Cancer Cell|August 16, 2017
A Viro-Immunotherapy Triple Play for the Treatment of GlioblastomaJohn C Bell, Carolina S Ilkow
Signal Transduction and Targeted Therapy|April 2, 2024
Optimizing oncolytic virus design: a "Swiss army knife" approach to create a systemically delivered therapeuticCarolina S Ilkow, John Cameron Bell
Methods in Molecular Biology (Clifton, N.J.)|December 31, 2022
Generation and Quantification of Cytotoxic Lymphocytes Following Oncolytic Virus Infection of Multi-cellular Tumor SpheroidsVictoria A Jennings, Carolina S Ilkow
Cancers|August 7, 2021
Oncolytic Virus ImmunotherapyAntonio Marchini, Carolina S Ilkow, Alan Melcher
Cytokine & Growth Factor Reviews|September 22, 2020
Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironmentTaylor R Jamieson, Joanna Poutou, Carolina S Ilkow
Cellular Microbiology|January 25, 2014
Phosphorylation and membrane association of the Rubella virus capsid protein is important for its anti-apoptotic functionSteven Willows, Carolina S Ilkow, Tom C Hobman
Plos Pathogens|March 8, 2011
The Rubella virus capsid is an anti-apoptotic protein that attenuates the pore-forming ability of BaxCarolina S Ilkow, Ing Swie Goping, Tom C Hobman
Future Microbiology|April 1, 2010
Rubella virus capsid protein: a small protein with big functionsCarolina S Ilkow, Steven D Willows, Tom C Hobman
Seminars in Immunology|June 26, 2025
A framework for the rational design of oncolytic viruses: A holistic perspective considering the tumour microenvironmentDylan Thomas, Priya Bharadwa, Timothy Lee, et al.
Cellular Signalling|February 9, 2008
Modulation of signaling pathways by RNA virus capsid proteinsMatthew D Urbanowski, Carolina S Ilkow, Tom C Hobman
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Cancer Cell|August 16, 2017
A Viro-Immunotherapy Triple Play for the Treatment of GlioblastomaJohn C Bell, Carolina S Ilkow
Signal Transduction and Targeted Therapy|April 2, 2024
Optimizing oncolytic virus design: a "Swiss army knife" approach to create a systemically delivered therapeuticCarolina S Ilkow, John Cameron Bell
Methods in Molecular Biology (Clifton, N.J.)|December 31, 2022
Generation and Quantification of Cytotoxic Lymphocytes Following Oncolytic Virus Infection of Multi-cellular Tumor SpheroidsVictoria A Jennings, Carolina S Ilkow
Cancers|August 7, 2021
Oncolytic Virus ImmunotherapyAntonio Marchini, Carolina S Ilkow, Alan Melcher
Cytokine & Growth Factor Reviews|September 22, 2020
Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironmentTaylor R Jamieson, Joanna Poutou, Carolina S Ilkow
Cellular Microbiology|January 25, 2014
Phosphorylation and membrane association of the Rubella virus capsid protein is important for its anti-apoptotic functionSteven Willows, Carolina S Ilkow, Tom C Hobman
Plos Pathogens|March 8, 2011
The Rubella virus capsid is an anti-apoptotic protein that attenuates the pore-forming ability of BaxCarolina S Ilkow, Ing Swie Goping, Tom C Hobman
Future Microbiology|April 1, 2010
Rubella virus capsid protein: a small protein with big functionsCarolina S Ilkow, Steven D Willows, Tom C Hobman
Seminars in Immunology|June 26, 2025
A framework for the rational design of oncolytic viruses: A holistic perspective considering the tumour microenvironmentDylan Thomas, Priya Bharadwa, Timothy Lee, et al.
Cellular Signalling|February 9, 2008
Modulation of signaling pathways by RNA virus capsid proteinsMatthew D Urbanowski, Carolina S Ilkow, Tom C Hobman
Pageof 5